Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 3 EP applications Clive Beresford Thompson has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 10, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12725349

COMPOSITIONS FOR PERCUTANEOUS ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE AGENTS

IPC classification:
A61K 47/32, A61K 9/70, A61K 9/00
Applicant:
Novartis AG
Agent:
Clive Beresford Thompson, GlaxoSmithKline
Agent:
Florian Bielefeldt, Novartis Consumer Health SA
Status:
GRANT OF PATENT INTENDED
EP14163452

Dispensing head for dispensing a viscous material from a container

IPC classification:
A45D 34/04, B65D 51/22, B65D 47/20, B65D 35/36
Applicant:
Novartis AG
Agent:
Clive Beresford Thompson, GlaxoSmithKline
Status:
APPLICATION REFUSED
EP16783825

NOVEL PROCESS

IPC classification:
A21D 2/40, A21D 2/18, C12N 9/32
Agent:
Clive Beresford Thompson, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature